Opko Health (OPK) Cash & Equivalents (2010 - 2026)
Opko Health's (OPK) quarterly Cash & Equivalents came in at $300.8 million in Q2 2026, up 10.69% on a YoY basis from $271.7 million in Q2 2025, and down 12.03% quarter-over-quarter from $341.9 million in Q1 2026.
Powered by 
Analysis
Opko Health (OPK) Cash & Equivalents (2010 - 2026) Analysis & Trends
Opko Health (OPK) has reported Cash & Equivalents for 17 consecutive years, with $300.8 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Cash & Equivalents rose 10.69% year-over-year to $300.8 million; the trailing twelve-month figure through Jun 2026 stood at $300.8 million (up 10.69% YoY), and the FY2025 full-year result was $369.1 million, down 14.55% from the prior year.
- Cash & Equivalents declined to $300.8 million in Q2 2026 per OPK's latest filing, from $341.9 million in the prior quarter.
- Across five years, Cash & Equivalents topped out at $436.0 million in Q1 2025 and bottomed at $40.6 million in Q2 2024.
- Historically, Cash & Equivalents has averaged $232.7 million across 5 years, with a median of $195.6 million in 2022.
- The sharpest annual moves came in 2024 and 2025: Cash & Equivalents slumped 62.47% in 2024, then soared 569.65% in 2025.
- Over 5 years, Cash & Equivalents stood at $153.2 million in 2022, then tumbled by 37.41% to $95.9 million in 2023, then surged by 350.49% to $431.9 million in 2024, then fell by 14.55% to $369.1 million in 2025, then declined by 18.51% to $300.8 million in 2026.
- According to Business Quant data, Cash & Equivalents over the past three periods registered $300.8 million, $341.9 million, and $369.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.65 Bn | 629.89 Bn | 17.26 Bn | 20.42 Bn |
| 2 | AbbVie | 466.34 Bn | 459.82 Bn | 12.70 Bn | 6.57 Bn |
| 3 | Merck | 362.11 Bn | 355.02 Bn | 12.21 Bn | 6.85 Bn |
| 4 | Novartis Ag | 267.81 Bn | 260.52 Bn | 11.24 Bn | 7.62 Bn |
| 5 | Pfizer | 157.31 Bn | 145.91 Bn | 10.94 Bn | 976.00 Mn |
| 6 | Bristol Myers Squibb | 128.75 Bn | 117.69 Bn | 9.25 Bn | 8.72 Bn |
| 7 | Sanofi | 51.80 Bn | 44.84 Bn | 10.79 Bn | 7.38 Bn |
| 8 | Revolution Medicines | 40.91 Bn | 40.91 Bn | - | 815.44 Mn |
| 9 | BeOne Medicines | 39.65 Bn | 34.55 Bn | 1.53 Bn | 5.10 Bn |
| 10 | Opko Health | 1.25 Bn | 945.61 Mn | 80.02 Mn | 300.76 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 300.76 Mn |
| Mar 31, 2026 | 341.88 Mn |
| Dec 31, 2025 | 369.07 Mn |
| Sep 30, 2025 | 415.20 Mn |
| Jun 30, 2025 | 271.72 Mn |
| Mar 31, 2025 | 436.00 Mn |
| Dec 31, 2024 | 431.94 Mn |
| Sep 30, 2024 | 406.40 Mn |
| Jun 30, 2024 | 40.58 Mn |
| Mar 31, 2024 | 75.64 Mn |
| Dec 31, 2023 | 95.88 Mn |
| Sep 30, 2023 | 138.62 Mn |
| Jun 30, 2023 | 108.11 Mn |
| Mar 31, 2023 | 110.83 Mn |
| Dec 31, 2022 | 153.19 Mn |
| Sep 30, 2022 | 180.84 Mn |
| Jun 30, 2022 | 210.46 Mn |
| Mar 31, 2022 | 102.28 Mn |
| Dec 31, 2021 | 134.71 Mn |
| Sep 30, 2021 | 148.60 Mn |
API Access
Opko Health Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=OPK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "OPK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=OPK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();